N-(3,4-dihydroxyphenethyl)-3-phenylpropanamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: N-(3,4-dihydroxyphenethyl)-3-phenylpropanamide
• 英文别名: N-(3-phenylpropanoyl) dopamine；N-[2-(3,4-Dihydroxyphenyl)ethyl]-3-phenylpropanamide
• 化学式: C₁₇H₁₉NO₃
• 分子量: 285.343
• InChiKey: AQTKQQPTLASVMQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  21
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  69.6
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-(3,4-dihydroxyphenethyl)-3-phenylpropanamide 、 犬尿胺二氢溴酸盐 在 cerium(III) chloride heptahydrate 、 碳酸氢钠 、 silver(l) oxide 作用下， 以 甲醇 、 溶剂黄146 为溶剂， 反应 2.0h， 生成 cystodytin-N14-3-phenylpropanamide
  参考文献：
  名称：

  Synthesis, DNA Binding and Antitumor Evaluation of Styelsamine and Cystodytin Analogues

  摘要：

  一系列N-14侧链取代的styelsamine（吡啶并[4,3,2-mn]吖啶）和cystodytin（吡啶并[4,3,2-mn]吖啶-4-酮）生物碱类似物已被制备并评估其结合DNA亲和力和对人类肿瘤细胞系的抗增殖活性。总体发现styelsamine类似物是更强的DNA结合剂，天然产物styelsamine B和D具有特别高的亲和力（Kapp分别为5.33 × 10^6 M^-1和3.64 × 10^6 M^-1）。相比之下，cystodytin亚胺醌生物碱对DNA的亲和力较低，但在抑制体外肿瘤细胞增殖方面通常与styelsamine类似物一样活跃。对于多个类似物，观察到对非小细胞肺癌、黑色素瘤和肾癌细胞系的亚组选择性。观察到整个细胞活性和clogP之间的相关性，最强烈的抗增殖活性在3-苯基丙酰胺类似物37和41中观察到（NCI面板平均GI50分别为0.4 μM和0.32 μM），clogP约为4.0-4.5。

  DOI：

  10.3390/md11020274
• 作为产物：
  描述：

  N-(3,4-dimethoxyphenethyl)-3-phenylpropanamide 在 三溴化硼 作用下， 以 二氯甲烷 为溶剂， 反应 20.0h， 以89%的产率得到N-(3,4-dihydroxyphenethyl)-3-phenylpropanamide
  参考文献：
  名称：

  Synthesis, DNA Binding and Antitumor Evaluation of Styelsamine and Cystodytin Analogues

  摘要：

  一系列N-14侧链取代的styelsamine（吡啶并[4,3,2-mn]吖啶）和cystodytin（吡啶并[4,3,2-mn]吖啶-4-酮）生物碱类似物已被制备并评估其结合DNA亲和力和对人类肿瘤细胞系的抗增殖活性。总体发现styelsamine类似物是更强的DNA结合剂，天然产物styelsamine B和D具有特别高的亲和力（Kapp分别为5.33 × 10^6 M^-1和3.64 × 10^6 M^-1）。相比之下，cystodytin亚胺醌生物碱对DNA的亲和力较低，但在抑制体外肿瘤细胞增殖方面通常与styelsamine类似物一样活跃。对于多个类似物，观察到对非小细胞肺癌、黑色素瘤和肾癌细胞系的亚组选择性。观察到整个细胞活性和clogP之间的相关性，最强烈的抗增殖活性在3-苯基丙酰胺类似物37和41中观察到（NCI面板平均GI50分别为0.4 μM和0.32 μM），clogP约为4.0-4.5。

  DOI：

  10.3390/md11020274

文献信息

• SUBTANCES FOR THE PROTECTION OF CELLS AND/OR TISSUES
  申请人：Losel Ralf

  公开号：US20100129436A1

  公开（公告）日：2010-05-27

  The invention relates to substances that are suitable for protecting cells and/or tissues.

  这项发明涉及适用于保护细胞和/或组织的物质。
• Hydroxylated Aromatic Inhibitors of HIV-1 Integrase
  作者：Terrence R. Jr. Burke、Mark Fesen、Abhijit Mazumder、Jessie Yung、Jian Wang、Adelaide M. Carothers、Dezider Grunberger、John Driscoll、Yves Pommier、Kurt Kohn

  DOI：10.1021/jm00021a006

  日期：1995.10

  Efficient replication of HIV-1 requires integration of a DNA copy of the viral genome into a chromosome of the host cell. Integration is catalyzed by the viral integrase, and we have previously reported that phenolic moieties in compounds such as flavones, caffeic acid phenethyl ester (CAFE, 2), and curcumin confer inhibitory activity against HIV-1 integrase. We now extend these findings by performing a comprehensive structure-activity relationship using CAPE analogues. Approximately 30 compounds have been prepared as HIV integrase inhibitors based on the structural lead provided by CAPE, which has previously been shown to exhibit an IC50 value of 7 mu M in our integration assay. These analogues were designed to examine specific features of the parent CAFE structure which may be important for activity. Among the features examined for their effects on inhibitory potency were ring substitution, side chain length and composition, and phenyl ring conformational orientation. In an assay which measured the combined effect of two sequential steps, dinucleotide cleavage and strand transfer, several analogues have IC50 values for 3'-processing and strand transfer lower than those of CAFE. Inhibition of strand transfer was assayed using both blunt-ended and ''precleaved'' DNA substrates. Disintegration using an integrase mutant lacking the N-terminal zinc finger and C-terminal DNA-binding domains was also inhibited by these analogues, suggesting that the binding site for these compounds resides in the central catalytic core. Several CAFE analogues were also tested for selective activity against transformed cells. Taken together, these results suggest that the development of novel antiviral agents for the treatment of acquired immune deficiency syndrome can be based upon inhibition of HIV-1 integrase.
• METHODS OF TREATING SKIN DISORDERS WITH CAFFEIC ACID ANALOGS
  申请人：CONRAD CHARLES

  公开号：US20080167277A1

  公开（公告）日：2008-07-10

  Methods of treating skin diseases such as plaque psoriasis and inverse psoriasis include topical application of one or a combination of caffeic acid phenethyl ester, caffeic acid benzyl ester, and analogs thereof as an active agent. A pharmaceutical composition containing the active agent may further include a cell differentiating agent such as a retinoid, and/or vitamin D or analogs thereof. The method enables treatment of a lesion with active agent dosages of ten percent by weight, for example.
• Synthesis, DNA Binding and Antitumor Evaluation of Styelsamine and Cystodytin Analogues
  作者：Hugo Fong、Brent Copp

  DOI：10.3390/md11020274

  日期：——

  A series of N-14 sidechain substituted analogues of styelsamine (pyrido[4,3,2-mn]acridine) and cystodytin (pyrido[4,3,2-mn]acridin-4-one) alkaloids have been prepared and evaluated for their DNA binding affinity and antiproliferative activity towards a panel of human tumor cell lines. Overall it was found that styelsamine analogues were stronger DNA binders, with the natural products styelsamines B and D having particularly high affinity (Kapp 5.33 × 106 and 3.64 × 106 M−1, respectively). In comparison, the cystodytin iminoquinone alkaloids showed lower affinity for DNA, but were typically just as active as styelsamine analogues at inhibiting proliferation of tumor cells in vitro. Sub-panel selectivity towards non-small cell lung, melanoma and renal cancer cell lines were observed for a number of the analogues. Correlation was observed between whole cell activity and clogP, with the most potent antiproliferative activity being observed for 3-phenylpropanamide analogues 37 and 41 (NCI panel average GI50 0.4 μM and 0.32 μM, respectively) with clogP ~4.0–4.5.

  一系列N-14侧链取代的styelsamine（吡啶并[4,3,2-mn]吖啶）和cystodytin（吡啶并[4,3,2-mn]吖啶-4-酮）生物碱类似物已被制备并评估其结合DNA亲和力和对人类肿瘤细胞系的抗增殖活性。总体发现styelsamine类似物是更强的DNA结合剂，天然产物styelsamine B和D具有特别高的亲和力（Kapp分别为5.33 × 10^6 M^-1和3.64 × 10^6 M^-1）。相比之下，cystodytin亚胺醌生物碱对DNA的亲和力较低，但在抑制体外肿瘤细胞增殖方面通常与styelsamine类似物一样活跃。对于多个类似物，观察到对非小细胞肺癌、黑色素瘤和肾癌细胞系的亚组选择性。观察到整个细胞活性和clogP之间的相关性，最强烈的抗增殖活性在3-苯基丙酰胺类似物37和41中观察到（NCI面板平均GI50分别为0.4 μM和0.32 μM），clogP约为4.0-4.5。